25.12
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
Aristeia Capital L.L.C. Acquires Shares of 43,235 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (AMPH) to Release Earnings on Wednesday - MarketBeat
Insider Sell: Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH) - GuruFocus
Raymond James Financial Inc. Acquires Shares of 92,904 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Is the Options Market Predicting a Spike in Amphastar (AMPH) Stock? - MSN
Take off with Amphastar Pharmaceuticals Inc (AMPH): Get ready for trading - Sete News
Adversity is less terrifying than hope: Inovio Pharmaceuticals Inc (INO) - Sete News
Envestnet Asset Management Inc. Sells 2,463 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Amphastar Pharmaceuticals Q1 2025 Earnings: Key Financial Updates Coming May 7What to Watch - Stock Titan
Barclays PLC Buys 10,334 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by Oberweis Asset Management Inc. - MarketBeat
Learn to Evaluate (AMPH) using the Charts - news.stocktradersdaily.com
Fuller & Thaler Asset Management Inc. Sells 127,841 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Anaphylaxis Treatment Market Size in 7MM is expected to grow at - openPR.com
Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest - Yahoo Finance
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Position Boosted by Marshall Wace LLP - MarketBeat
Epoch Investment Partners Inc. Decreases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes - ACCESS Newswire
Mesirow Institutional Investment Management Inc. Has $14.12 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
JPMorgan Chase & Co. Has $5.70 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Legal & General Group Plc Sells 3,871 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by LPL Financial LLC - Defense World
BofA Adjusts Price Target on Amphastar Pharmaceuticals to $31 From $36 - marketscreener.com
U.S. Naloxone Market Is Booming So Rapidly 2025-2032 -Amphastar Pharmaceuticals Inc., Emergent BioSolutions Inc - openPR.com
BofA Adjusts Price Target for Amphastar (AMPH) Amid Q1 Uncertain - GuruFocus
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by LSV Asset Management - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stake Lessened by Portolan Capital Management LLC - MarketBeat
JPMorgan Chase & Co. Sells 385,349 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Renaissance Technologies LLC Acquires 36,100 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year LowShould You Sell? - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Alliancebernstein L.P. - Defense World
Geode Capital Management LLC Lowers Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar stock hits 52-week low at $22.73 amid market challenges By Investing.com - Investing.com South Africa
Amphastar stock hits 52-week low at $22.73 amid market challenges - Investing.com Canada
Bessemer Group Inc. Buys 11,609 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Franklin Resources Inc. Sells 1,060 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Pharma Stock to Buy for Long Term Growth? - Insider Monkey
2 Reasons to Like AMPH and 1 to Stay Skeptical - Yahoo Finance
Amphastar Pharmaceuticals' (AMPH) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Wellington Management Group LLP - Defense World
Hyaluronidase Market Growth, Trends & Insights 2024-2031 | Top - openPR.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):